The Board of Directors appointed Mrs. Priyanka Agarwal, member of ICSI (A36112) as the Company Secretary & Compliance Officer of the Company w.e.f 26th April 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Venmax Drugs and Pharmaceuticals Ltd, at its meeting held on April 26, 2025, approved the appointment of Mrs. Priyanka Agarwal as the new Company Secretary and Compliance Officer of the company with immediate effect. Mrs. Priyanka Agarwal is an Associate Member of the Institute of Company Secretaries of India (ICSI) with membership number 36112 and holds a Bachelor degree in Business Administration from Gyan Jyothi College. The appointment was made under Section 203 of the Companies Act, 2013 and Regulation 6 of the SEBI (LODR) Regulations, 2015, based on the recommendation of the Nomination and Remuneration Committee. The board meeting commenced at 5:00 PM and concluded at 5:40 PM on the same day.
This is a routine corporate governance update to fill the Company Secretary & Compliance Officer role. There is no material financial impact on shareholders or the stock price from this announcement.